investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Function and targeting of a stable transcription factor complex in leukemia
Robert G Roeder
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Robert G Roeder
Rockefeller University
New York, United States
Related projects
Xuefang Cao
Targeting Granzyme B to Separate GVH from GVL Responses
Leukaemia
Charalampos Kalodimos
Mechanisms of autoinhibition and activation of the Abl kinase
Leukaemia
Carol Prives
Properties and Regulation of p53 in Tumor Cells
Leukaemia
Pathology
Scott Moore Carlson
The role of PRDM1 in epigenetic regulation and tumor suppression
Leukaemia
David H Haussler
Center for Big Data in Translational Genomics
Leukaemia
Omar Abdel-Wahab
Role of ASXL1 mutations in myeloid malignancies
Leukaemia
Suresh Ambudkar
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
Leukaemia
Pathology
Hematology and hematologic malignancies
Richard A Flavell
Understanding Hemotopoietic Neoplasias using Humanized Mice
Leukaemia
Pathology
Hematology and hematologic malignancies
Alex Kentsis
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
Leukaemia